+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2026-2032- Product Image
Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2026-2032- Product Image
Sale

Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138645
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Lipocalin-2/NGAL ELISA Kit Market is projected to reach USD 115.68 Million in 2026. It is expected to continue growing at a CAGR of 6.39%, reaching USD 167.21 Million by 2032.

Human Lipocalin-2/NGAL ELISA Kits: Executive Summary

Human Lipocalin-2/NGAL ELISA kits are laboratory immunoassays used to quantify neutrophil gelatinase-associated lipocalin (NGAL), a biomarker investigated in kidney injury, inflammation, infection, and related biomedical applications. Demand is shaped by translational research, clinical validation activity, laboratory quality requirements, and the need for reproducible measurement across biological samples. This summary focuses on evidence-based industry dynamics without estimating market size, shares, or growth rates.

Research Complexity and Laboratory Standardization Are Reshaping Adoption

The landscape is shifting toward more standardized biomarker workflows, stronger analytical validation, and clearer separation between exploratory research use and clinically validated applications. Laboratories increasingly evaluate antibody specificity, calibration practices, matrix compatibility, limit of detection, precision, recovery, lot consistency, and protocol reproducibility before adopting an assay. Multiplexing, automation, smaller sample volumes, and digital laboratory records are also influencing kit selection, while regulatory expectations and institutional quality systems encourage documented performance verification.

Artificial Intelligence Is Improving Assay Development and Result Interpretation

Artificial intelligence can support literature screening, biomarker discovery, experimental design, image and signal analysis, anomaly detection, and quality-control review for NGAL-related studies. Machine-learning tools may help identify relationships between NGAL concentrations and clinical variables, but their outputs remain dependent on representative datasets, validated reference methods, and careful control of confounding factors. For ELISA workflows, AI should augment-not replace-analytical validation, human review, sample traceability, and compliance with applicable laboratory and data-governance requirements.

Regional Insights: Regulation, Research Capacity, and Infrastructure Define Adoption

North America benefits from advanced biomedical research infrastructure, established laboratory quality systems, and active investigation of renal and inflammatory biomarkers. Europe emphasizes harmonized quality practices, ethical oversight, and cross-border research comparability, while the European regulatory environment places strong attention on performance evidence and data integrity. Asia-Pacific combines expanding research capacity with substantial variation in laboratory infrastructure, procurement processes, and assay standardization. Latin America is supported by growing academic and clinical research activity but may face importation, funding, and cold-chain constraints. The Middle East is developing specialized healthcare and research capabilities, with adoption influenced by institutional investment and laboratory accreditation. Africa presents a diverse landscape in which access, supply continuity, technical training, and locally relevant validation are central considerations.

Group Insights: Economic and Security Blocs Influence Research Coordination

ASEAN markets reflect varied levels of laboratory modernization and regulatory maturity, making distributor support, training, and protocol harmonization important. BRICS members span large and diverse research systems, with domestic production capacity, procurement policy, and access to validated reagents influencing implementation. The European Union benefits from coordinated research networks and shared regulatory principles, although national laboratory practices still vary. G7 countries generally combine strong biomedical infrastructure with rigorous quality expectations. GCC states are investing in advanced healthcare and laboratory capabilities, while dependence on specialized imports can make supply resilience important. NATO members include highly developed research and health systems alongside more varied partner environments, so interoperability and continuity of critical laboratory supplies remain relevant.

Country Insights: National Research Priorities and Laboratory Systems Matter

Australia and Canada have strong academic and clinical research environments, with adoption influenced by institutional validation and procurement standards. Brazil and Mexico combine substantial research potential with regional differences in infrastructure and access. China and India have broad biomedical ecosystems and growing laboratory capacity, while local regulatory processes, quality assurance, and supply continuity remain important. Japan and South Korea emphasize technical precision, advanced instrumentation, and disciplined laboratory workflows. France, Germany, Italy, Spain, and the United Kingdom are supported by established research and healthcare systems, with attention to evidence quality, ethics, and regulatory compliance. Russia’s research environment is shaped by domestic capacity, procurement conditions, and access to international reagents. In the United States, high research intensity and sophisticated laboratory networks support extensive biomarker investigation, alongside stringent expectations for assay performance and documentation.

Action Priorities for Leaders: Prove Performance, Strengthen Supply, and Support Users

Industry leaders should publish transparent analytical-performance data covering precision, specificity, sensitivity, linearity, recovery, interference, and matrix effects, with clear intended-use statements. They should strengthen lot-to-lot controls, reference-material strategies, temperature monitoring, and contingency sourcing for critical components. Regional operating models should be adapted to local regulatory and infrastructure conditions rather than treated uniformly. Technical support, multilingual protocols, training, troubleshooting, and digital documentation can improve reproducibility. Leaders should also establish responsible AI governance, protect research data, monitor post-purchase performance, and collaborate with independent laboratories to support external validation.

Research Methodology: Evidence-Based Synthesis Without Market Estimation

This executive summary uses the specified product category-human Lipocalin-2/NGAL ELISA kits-as the analytical scope and organizes findings across technology, laboratory practice, regulation, geography, economic groupings, and countries. Insights are derived from established characteristics of immunoassay workflows, biomarker research, laboratory quality management, healthcare infrastructure, and regional research environments. The assessment intentionally excludes market estimates, market sizing, forecasts, market shares, and company-specific analysis. Interpretations should be validated against current product documentation, applicable regulatory requirements, peer-reviewed studies, and local procurement conditions before operational decisions are made.

Conclusion: Reliable NGAL Measurement Depends on Validation and Context

The human Lipocalin-2/NGAL ELISA kit landscape is being shaped by biomarker research, demand for reproducible laboratory evidence, automation, data-enabled workflows, and increasingly formal quality expectations. Adoption conditions differ across regions, economic groups, and countries because infrastructure, regulation, funding, and supply access are not uniform. Leaders that combine rigorous analytical validation with resilient distribution, practical user support, and responsible data practices will be better positioned to serve research and laboratory needs while maintaining confidence in NGAL measurement.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Lipocalin-2/NGAL ELISA Kit Market, by Sample Type
7.1. Introduction
7.2. Plasma
7.3. Serum
7.4. Urine
8. Human Lipocalin-2/NGAL ELISA Kit Market, by Kit Format
8.1. Introduction
8.2. 96 Well Microplate
8.3. Point Of Care Device
8.4. Strip Well
9. Human Lipocalin-2/NGAL ELISA Kit Market, by Reaction Principle
9.1. Introduction
9.2. Competitive ELISA
9.3. Indirect ELISA
9.4. Sandwich ELISA
10. Human Lipocalin-2/NGAL ELISA Kit Market, by Application Area
10.1. Introduction
10.2. Cancer Biomarker Detection
10.3. Cardiovascular Disease Assessment
10.4. Inflammatory Disease Studies
10.4.1. Rheumatoid Arthritis
10.4.2. Sepsis
10.5. Kidney Disease Diagnosis
10.5.1. Acute Kidney Injury
10.5.2. Chronic Kidney Disease
11. Human Lipocalin-2/NGAL ELISA Kit Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Field Force
11.2.2. Tender Sales
11.3. Distributors
11.3.1. Local Distributors
11.3.2. National Distributors
11.4. E Commerce
11.4.1. Manufacturer Website
11.4.2. Online Marketplace
12. Human Lipocalin-2/NGAL ELISA Kit Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Human Lipocalin-2/NGAL ELISA Kit Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Human Lipocalin-2/NGAL ELISA Kit Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abcam plc
16.2. Bio-Rad Laboratories, Inc.
16.3. Bio-Techne Corporation
16.4. BioVendor - Laboratorni medicína a.s.
16.5. Boster Biological Technology Co., Ltd.
16.6. Enzo Biochem, Inc.
16.7. Merck KGaA
16.8. RayBiotech, Inc.
16.9. Sino Biological Inc.
16.10. Thermo Fisher Scientific Inc.
16.11. Wuhan Fine Biotech Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Lipocalin-2/NGAL ELISA Kit Market, Years Considered for the Study
FIGURE 2. Global Human Lipocalin-2/NGAL ELISA Kit Market, Research Design
FIGURE 3. Global Human Lipocalin-2/NGAL ELISA Kit Market, Research Framework
FIGURE 4. Global Human Lipocalin-2/NGAL ELISA Kit Market, Data Triangulation
FIGURE 5. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2025 vs 2032 (%)
FIGURE 9. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2025 vs 2032 (%)
FIGURE 11. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2025 vs 2032 (%)
FIGURE 13. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Human Lipocalin-2/NGAL ELISA Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Lipocalin-2/NGAL ELISA Kit Market Segmentation & Coverage
TABLE 2. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 4. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 14. Global 96 Well Microplate Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 96 Well Microplate Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 96 Well Microplate Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Point Of Care Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Point Of Care Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Point Of Care Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Strip Well Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Strip Well Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Strip Well Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 24. Global Competitive ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Competitive ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Competitive ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Indirect ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Indirect ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Indirect ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Sandwich ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Sandwich ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Sandwich ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 34. Global Cancer Biomarker Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cancer Biomarker Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cancer Biomarker Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Cardiovascular Disease Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cardiovascular Disease Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Disease Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Inflammatory Disease Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Inflammatory Disease Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Inflammatory Disease Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Sepsis Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Sepsis Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Sepsis Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Kidney Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Kidney Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Kidney Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Acute Kidney Injury Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Acute Kidney Injury Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Acute Kidney Injury Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Chronic Kidney Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Chronic Kidney Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Chronic Kidney Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 59. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Field Force Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Field Force Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Field Force Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Tender Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Tender Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Tender Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Local Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Local Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Local Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global National Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global National Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global National Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global E Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global E Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global E Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Manufacturer Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Manufacturer Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Manufacturer Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Online Marketplace Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Online Marketplace Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Online Marketplace Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 98. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 100. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 101. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 102. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 103. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 104. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 105. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 107. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 108. North America Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 109. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 111. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 112. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 113. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 114. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 115. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 116. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 118. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 119. Latin America Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 120. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 122. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 123. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 124. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 125. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 126. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 127. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 129. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 130. Europe Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 131. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 133. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 134. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 135. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 136. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 137. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 138. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 140. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 141. Middle East Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 142. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 144. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 145. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 146. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 147. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 148. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 149. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 151. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 152. Africa Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 153. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 157. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 158. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 159. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 160. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 161. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 163. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 164. ASEAN Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 165. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 168. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 169. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 170. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 171. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 172. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 174. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 175. GCC Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 176. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 178. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 179. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 180. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 181. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 182. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 183. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 185. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 186. European Union Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 187. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 190. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 191. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 192. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 193. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 194. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 196. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 197. BRICS Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 198. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 201. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 202. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 203. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 204. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 205. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 207. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 208. G7 Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 209. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 211. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 212. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 213. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 214. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 215. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 216. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 218. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 219. NATO Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 220. Global Human Lipocalin-2/NGAL ELISA Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 222. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 223. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 224. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 225. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 226. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 227. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 228. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 230. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 231. United States Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 232. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 233. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 234. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 235. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 236. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 237. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 238. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 239. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 241. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 242. Canada Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 243. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 244. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 245. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 246. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 247. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 248. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 249. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 250. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 252. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 253. Mexico Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 254. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 255. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 256. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 257. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 258. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 259. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 260. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 261. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 263. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 264. Brazil Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 265. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 266. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 267. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 268. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 269. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 270. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 271. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 272. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 274. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 275. United Kingdom Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 276. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 277. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 278. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 279. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 280. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 281. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 282. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 283. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 285. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 286. Germany Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 287. France Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 288. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 289. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 290. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 291. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 292. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 293. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 294. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 296. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 297. France Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 298. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 299. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 300. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 301. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 302. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 303. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 304. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 305. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 306. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 307. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 308. Russia Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 309. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million)
TABLE 310. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 311. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kit Format, 2017-2032 (USD Million)
TABLE 312. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Reaction Principle, 2017-2032 (USD Million)
TABLE 313. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 314. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Inflammatory Disease Studies, 2017-2032 (USD Million)
TABLE 315. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Kidney Disease Diagnosis, 2017-2032 (USD Million)
TABLE 316. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Direct Sales, 2017-2032 (USD Million)
TABLE 318. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 319. Italy Human Lipocalin-2/NGAL ELISA Kit Market Size, by E Commerce, 2017-2032 (USD Million)
TABLE 320. Spain Human Lipocalin-2/NGAL ELISA Kit Market Size, 2017-2032 (USD Million

Companies Mentioned

  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioVendor – Laboratorni medicína a.s.
  • Boster Biological Technology Co., Ltd.
  • Enzo Biochem, Inc.
  • Merck KGaA
  • RayBiotech, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
  • Wuhan Fine Biotech Co., Ltd.

Related Topics

Related Reports

Human Gastrin ELISA Kit Market - Global Forecast 2026-2032 - Product Image

Human Gastrin ELISA Kit Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Eosinophil Peroxidase ELISA Kit Market - Global Forecast 2026-2032 - Product Image

Eosinophil Peroxidase ELISA Kit Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 262 Pages
  • Global
From
Human Bone Morphogenetic Protein 9 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Human Bone Morphogenetic Protein 9 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Animal IL-6 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Animal IL-6 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.